SureTrader Nadex Advertisement PGUS
Home > Boards > US OTC > Biotechs >

IMMUDYNE INC (IMMD)

IMMD RSS Feed
Add IMMD Price Alert      Hide Sticky   Hide Intro
Moderator: xrymd, Suvorov
Search This Board: 
Last Post: 3/24/2017 7:13:09 PM - Followers: 52 - Board type: Free - Posts Today: 0


 

IMMUDYNE, INC. (OTCQB: IMMD)
 

Immudyne, Inc. (OTCQB: IMMD) is a science-based wellness & healthcare company. Immudyne manufactures and sells clinically researched, doctor-recommended, yeast beta-1, 3 / 1, 6-D-glucan dietary supplements and topical skin lines.

 

PuraCere: Empower Your Immune Health

Your immune system controls your skin’s health and appearance. From regeneration and protection, to clearing of scars and acne. Activated, topical immune cells heal microscopic wounds, fight against infection, regenerate your skin, and counteract the damage from UV-ray exposure, environmental toxins, and the aging process.

PURACERETM is a naturally powerful immune support supplement. Through a proprietary process, PURACERE is extracted from Saccharomyces cerevisiae producing the purist yeast beta-1, 3 / 1, 6-D-glucan available. Hundreds of clinical studies confirm that yeast beta-1, 3 / 1, 6-D-glucans are powerful immunomodulators.

 

Products: iNR Wellness,  iNR Wellness MD,  iNR Strength,  NAYAD Serum

iNR Wellness MD is a nutritional supplement that naturally empowers your immune system with PURACERE™, IP-6, and a vitamin C complex. PURACERE is a naturally powerful immune support supplement and clinically proven to provide immune health benefits. This is why iNR Wellness MD is recommended by doctors and medical experts worldwide.

iNR STRENGTH is a nutritional supplement that naturally supports the immune system with PURACERE™ and antioxidants. PURACERE is a naturally powerful immune support supplement and clinically proven to provide immune health benefits. iNR Strength also contains the antioxidants riboflavin and thiamine, to help support energy conversion into lean muscle. This is why iNR Strength is recommended by health and wellness experts worldwide.

NAYAD Rejuvenating Serum

NAYAD is an ultrapure, topical beta-1,3/1,6-D-glucan. NAYAD is a naturally derived skincare solution that has been clinically proven to provide powerful anti-aging results. NAYAD stimulates collagen production and natural cell renewal. Scientific studies have shown that NAYAD directly connects with and activates Langerhans cells. Langerhans cells are topical immune cells. When activated, they heal microscopic wounds, fight against infection, regenerate your skin, and counteract the damage from UV-ray exposure, environmental toxins, and the aging process.

 

Management

Anthony G. Bruzzese, MD, Chairman
Mark McLaughlin, President and CEO
Sven Rohmann, MD, PhD, Global Chief Medical Officer
Joseph V. DiTrolio, MD, Chief Medical Officer, US
John Strawn, Esq., Legal


Company Ticker:    IMMD

# Shares Outstanding:    30 MM

No Debt

Average Daily Volume:    38,000

52 week range:    $0.05 – $0.41

S.E.C. Counsel: Kane Kessler 

Auditor: PKF O’Connor Davies

For further information, please contact: Immudyne, Inc.

Mark McLaughlin President & CEO

+1-914-714-8901

MarkMcL@immudyne.com

 

 

 

The Daily View



The Weekly View






 

Moderator's Disclaimer - This board is for (IMMD) discussion purposes only and is in no way a recommendation to buy or sell. Any investment decisions should be based on your own due diligence and decision. You are solely responsible for your choices to buy or sell.

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IMMD
Current Price
Volume:
Bid Ask Day's Range
SureTrader
IMMD News: ImmuDyne Announces Completion of Shapiro MD Formulation Work and Update on Launch 03/23/2017 08:30:00 AM
IMMD News: Amended Current Report Filing (8-k/a) 03/08/2017 09:46:28 AM
IMMD News: ImmuDyne Provides 2017 Business Outlook 03/06/2017 09:05:45 AM
IMMD News: ImmuDyne Appoints Chief Operating Officer/Chief Technology Officer 02/23/2017 08:30:00 AM
IMMD News: ImmuDyne: Second Patent Issued for Topical Treatment of Hair Loss/Alopecia; Q1 Launch Scheduled 01/24/2017 08:00:00 AM
PostSubject
#2414   50 DMA rising quick @ 36 - as puffadder 03/24/17 07:13:09 PM
#2413   I have done very well with charts, Suvorov 03/24/17 05:26:36 PM
#2412   There are lower lows and lower highs since Suvorov 03/24/17 05:24:21 PM
#2409   Happy, calm down, I don't want to fight Suvorov 03/24/17 04:48:15 PM
#2407   Somebody getting a bunch of 56's puffadder 03/24/17 03:53:00 PM
#2405   Dead cat bounce lol - we'll see puffadder 03/24/17 08:40:56 AM
#2403   I stand by my chart analysis, IMMD .35, Suvorov 03/24/17 05:54:05 AM
#2402   The Charts still predict IMMD going to .35.. Suvorov 03/24/17 05:52:38 AM
#2401   Chart analytics have made me wealthy...... Suvorov 03/24/17 05:51:30 AM
#2400   Hopefully stays in this range for another week puffadder 03/23/17 08:10:31 PM
#2398   Right now the weekly chart is neither bullish Happy Investor 03/23/17 06:19:25 PM
#2397   People who live and die by the charts Happy Investor 03/23/17 06:16:13 PM
#2396   Forget about 35 - not gonna happen puffadder 03/23/17 09:34:43 AM
#2395   Lets hope that this news can keep the manfromjax 03/23/17 09:19:12 AM
#2394   Chart is not bullish, it is bearish.. Suvorov 03/23/17 06:44:54 AM
#2393   Chart very much bullish puffadder 03/22/17 05:08:27 PM
#2392   Nice to see it holding the 20dma manfromjax 03/22/17 04:20:56 PM
#2391   Well that's all the way back to the puffadder 03/22/17 07:32:22 AM
#2390   Hate to rain on the pumper parade but Suvorov 03/22/17 06:24:14 AM
#2389   Agree $170 mil mkt cap very doable puffadder 03/21/17 10:33:18 PM
#2388   that seems a bit aggressive but $5 is xrymd 03/21/17 10:27:33 PM
#2387   If it does IMMD is a $30 stock puffadder 03/21/17 09:51:47 PM
#2386   I'm going to get a hold of about xrymd 03/21/17 09:01:51 PM
#2385   No problem - if this formula is even close puffadder 03/21/17 07:35:43 PM
#2384   No question - charts are great to determine puffadder 03/21/17 05:55:16 PM
#2383   While I use charts, they should never be Happy Investor 03/21/17 05:48:41 PM
#2382   Needs to hold .50 - not sure why puffadder 03/21/17 04:49:27 PM
#2381   The Good, the Bad and the Ugly manfromjax 03/21/17 04:42:46 PM
#2380   Re-test of .50 range puffadder 03/21/17 12:57:02 PM
#2379   Bounced off .50 like a charm puffadder 03/21/17 12:14:44 PM
#2378   Well, it look like we will soon find manfromjax 03/21/17 11:17:41 AM
#2377   I didn't say it was going to 30 Suvorov 03/21/17 10:29:08 AM
#2376   True - pretty well an unknown right now puffadder 03/21/17 10:15:26 AM
#2375   $.30 - not gonna happen - support puffadder 03/21/17 10:13:34 AM
#2374   You are probably correct. There is very Happy Investor 03/21/17 10:08:04 AM
#2373   I don't like to rain on your chart Suvorov 03/21/17 10:06:21 AM
#2372   I know the 3 main hair restoring xrymd 03/20/17 08:50:33 PM
#2371   Chart is stellar and float is ideal ... puffadder 03/20/17 03:06:18 PM
#2370   Looks like trading volume is drying up. manfromjax 03/20/17 01:05:01 PM
#2369   No. The board and advisory board consists Happy Investor 03/17/17 03:37:36 PM
#2368   I stand by my statements and I Suvorov 03/17/17 12:38:06 PM
#2367   Happy Investor .. puffadder 03/17/17 12:37:58 PM
#2366   Don't tell me that I am pitching. Happy Investor 03/17/17 12:01:58 PM
#2365   Would have to look at active ingredients .. puffadder 03/17/17 11:17:03 AM
#2364   Just like the FDA passed thalidomide in 1961. Suvorov 03/17/17 10:53:36 AM
#2363   Ditto. I think those concerned with debt Happy Investor 03/17/17 10:15:47 AM
#2362   While the product may invade the scalp, it Happy Investor 03/17/17 10:06:37 AM
#2361   Marks raises have always been small and mostly xrymd 03/17/17 09:08:03 AM
#2360   Agreed. However, if they have a 'for sure' product Suvorov 03/17/17 08:28:56 AM
#2359   No debt is unheard of in otc land puffadder 03/16/17 08:08:19 PM
PostSubject